Please try another search
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Lawrence Geiter | - | - | Member of Scientific Advisory Board |
Rakesh Dixit | - | - | Member of Scientific Advisory Board |
Sejin Park | 62 | 2024 | CFO, COO, Vice President & Director |
Yong Zu Kim | 68 | - | CEO, President & Director |
Lee Seungho | - | 2024 | Independent Outside Director |
Robert J. Lutz | - | - | Member of Scientific Advisory Board |
Morris Z. Rosenberg | 64 | - | Member of Scientific Advisory Board |
Seo Won Dam | - | 2024 | Director |
In-Cheol Heo | - | 2024 | Director |
Hyung-Seok Kim | 61 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review